Acorda Therapeutics Probability of Future Stock Price Finishing Over 16.60
| ACORDelisted Stock | USD 16.20 0.40 2.41% |
Acorda |
Acorda Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acorda Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acorda Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acorda Therapeutics is not yet fully synchronised with the market data | |
| Acorda Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M. | |
| Acorda Therapeutics currently holds about 20.7 M in cash with (13.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. |
Acorda Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acorda Stock often depends not only on the future outlook of the current and potential Acorda Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acorda Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 30.4 M |
Acorda Therapeutics Technical Analysis
Acorda Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Acorda Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acorda Therapeutics. In general, you should focus on analyzing Acorda Stock price patterns and their correlations with different microeconomic environments and drivers.
Acorda Therapeutics Predictive Forecast Models
Acorda Therapeutics' time-series forecasting models is one of many Acorda Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acorda Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Acorda Therapeutics
Checking the ongoing alerts about Acorda Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acorda Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acorda Therapeutics is not yet fully synchronised with the market data | |
| Acorda Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M. | |
| Acorda Therapeutics currently holds about 20.7 M in cash with (13.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |